EcoDrugPlus

Disintegrin And Metalloproteinase Domain-Containing Protein 17

Ensembl ID : ENSCSEG00000001636
Gene Symbol: LOC103377555
3 Cross references
209 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSCSEG00000014779
Gene Symbol: DRD1
3 Cross references
201 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSCSEG00000020160
Gene Symbol: DRD1
2 Cross references
189 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSCSEG00000016534
Gene Symbol: DRD2
3 Cross references
207 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSCSEG00000017041
Gene Symbol: DRD3
3 Cross references
203 Possible Orthologues:

Dopamine Receptor D4a

Ensembl ID : ENSCSEG00000021206
Gene Symbol: DRD4A
1 Cross references
174 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSCSEG00000008580
Gene Symbol: DRD5
4 Cross references
164 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSCSEG00000018526
Gene Symbol: ENPP2
1 Cross references
226 Possible Orthologues:

Egl Nine Homolog 2-Like

Ensembl ID : ENSCSEG00000008308
Gene Symbol: LOC103378094
2 Cross references
195 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSCSEG00000013108
Gene Symbol: EGLN1
3 Cross references
216 Possible Orthologues:

Egl-9 Family Hypoxia-Inducible Factor 3

Ensembl ID : ENSCSEG00000012988
Gene Symbol: EGLN3
1 Cross references
200 Possible Orthologues:

Endothelial Pas Domain-Containing Protein 1

Ensembl ID : ENSCSEG00000018276
Gene Symbol: LOC103387795
3 Cross references
211 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).